Roe, Denise J.

Efficacy of Lenalidomide in Myelodysplastic Syndromes

List, A., Kurtin, S., Roe, D. J., Buresh, A., Mahadevan, D., Fuchs, D., Rimsza, L., Heaton, R., Knight, R., & Zeldis, J. B. (2005) · New England Journal of Medicine

Acute Myeloid Leukemia ResearchErythropoietin and Anemia Treatment

Cited by 880

Phase III Trial of Ursodeoxycholic Acid To Prevent Colorectal Adenoma Recurrence

Alberts, D. S., Martínez, M. E., Hess, L. M., Einspahr, J. G., Green, S. B., Bhattacharyya, A. K., Guillen, J., Krutzsch, M., Batta, A. K., Salen, G., et al. (2005) · JNCI: Journal of the National Cancer Institute

Colorectal Cancer Screening and DetectionColorectal Cancer Treatments and Studies

Cited by 247

The antitumor thioredoxin-1 inhibitor PX-12 (1-methylpropyl 2-imidazolyl disulfide) decreases thioredoxin-1 and VEGF levels in cancer patient plasma

Baker, A. F., Dragovich, T., Tate, W. R., Ramanathan, R. K., Roe, D., Hsu, C.-H., Kirkpatrick, D. L., & Powis, G. (2006) · Journal of Laboratory and Clinical Medicine

Redox biology and oxidative stressGlutathione Transferases and Polymorphisms

Cited by 90

Risk of Mortality According to Body Mass Index and Body Composition Among Postmenopausal Women

Bea, J. W., Thomson, C. A., Wertheim, B. C., Nicholas, J. S., Ernst, K. C., Hu, C., Jackson, R. D., Cauley, J. A., Lewis, C. E., Caan, B., et al. (2015) · American Journal of Epidemiology

Cancer Risks and FactorsBody Composition Measurement Techniques

Cited by 48

Distinct sets of molecular characteristics define tumor-rejecting neoantigens

Adams, A. C., Macy, A. M., Borden, E. S., Herrmann, L. M., Brambley, C. A., Ma, T., Li, X., Hughes, A., Roe, D. J., Mangold, A. R., et al. (2024) · Journal for ImmunoTherapy of Cancer

Immunotherapy and Immune ResponsesCancer Immunotherapy and Biomarkers

Cited by 4

Structural changes from wild-type define tumor-rejecting neoantigens

Adams, A. C., Macy, A. M., Borden, E. S., Herrmann, L. M., Brambley, C. A., Sonar, S. A., Ma, T., Li, X., Hughes, A., Roe, D. J., et al. (2025) · Journal for ImmunoTherapy of Cancer

Immunotherapy and Immune ResponsesCancer Immunotherapy and Biomarkers

Cited by 4